Quantification of tumor vasculature by PECAM-1 immunostaining showed 59% ±9.3 reduction of vascular area in GKT136901-treated tumors as compared to vehicle treated animals (Figure 6d). The gene discussed is PECAM1; the disease is neoplasm.